Literature DB >> 8316218

Mechanisms of excision of 5-fluorouracil by uracil DNA glycosylase in normal human cells.

D J Mauro1, J K De Riel, R J Tallarida, M A Sirover.   

Abstract

Recent evidence indicates that 5-fluorouracil (5-FlUra) is incorporated into DNA and is removed by the DNA repair enzyme uracil DNA glycosylase. Synthetic oligonucleotides containing either a single uracil or 5-FlUra residue were constructed to examine the mechanisms by which human cells remove 5-FlUra from DNA. The human uracil DNA glycosylase excised uracil in a manner similar to that observed for the bacterial enzyme. In contrast, a significant difference was observed in their abilities to remove 5-FlUra. In particular, both the bacterial and normal human enzymes displayed 13-17-fold increases in their apparent Km values but the apparent Vmax values remained virtually constant. These results demonstrate that normal human cells possess a defined capacity to remove 5-FlUra incorporated into DNA. However, specific kinetic differences may exist that affect their capacity to remove 5-FlUra formed in DNA after treatment with this cancer chemotherapeutic agent.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8316218

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  11 in total

1.  Protonation preferentially stabilizes minor tautomers of the halouracils: IRMPD action spectroscopy and theoretical studies.

Authors:  K T Crampton; A I Rathur; Y-w Nei; G Berden; J Oomens; M T Rodgers
Journal:  J Am Soc Mass Spectrom       Date:  2012-07-21       Impact factor: 3.109

2.  Targeting Histone Chaperone FACT Complex Overcomes 5-Fluorouracil Resistance in Colon Cancer.

Authors:  Heyu Song; Jiping Zeng; Shrabasti Roychoudhury; Pranjal Biswas; Bhopal Mohapatra; Sutapa Ray; Kayvon Dowlatshahi; Jing Wang; Vimla Band; Geoffrey Talmon; Kishor K Bhakat
Journal:  Mol Cancer Ther       Date:  2019-10-01       Impact factor: 6.261

Review 3.  Modulation of 5-fluorouracil by interferon: a review of potential cellular targets.

Authors:  R Horowitz; E L Schwartz; S Wadler
Journal:  Med Oncol       Date:  1995-03       Impact factor: 3.064

4.  Characterization of uracil-DNA glycosylase activity from Trypanosoma cruzi and its stimulation by AP endonuclease.

Authors:  M E Fárez-Vidal; C Gallego; L M Ruiz-Pérez; D González-Pacanowska
Journal:  Nucleic Acids Res       Date:  2001-04-01       Impact factor: 16.971

Review 5.  5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development.

Authors:  J L Grem
Journal:  Invest New Drugs       Date:  2000-11       Impact factor: 3.850

6.  Human cytomegalovirus uracil DNA glycosylase is required for the normal temporal regulation of both DNA synthesis and viral replication.

Authors:  M N Prichard; G M Duke; E S Mocarski
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

Review 7.  Participation of DNA repair in the response to 5-fluorouracil.

Authors:  M D Wyatt; D M Wilson
Journal:  Cell Mol Life Sci       Date:  2009-03       Impact factor: 9.261

8.  Excision of 5-halogenated uracils by human thymine DNA glycosylase. Robust activity for DNA contexts other than CpG.

Authors:  Michael T Morgan; Matthew T Bennett; Alexander C Drohat
Journal:  J Biol Chem       Date:  2007-06-29       Impact factor: 5.157

9.  Genomically Incorporated 5-Fluorouracil that Escapes UNG-Initiated Base Excision Repair Blocks DNA Replication and Activates Homologous Recombination.

Authors:  Amelia M Huehls; Catherine J Huntoon; Poorval M Joshi; Carly A Baehr; Jill M Wagner; Xiaoxiao Wang; Marietta Y Lee; Larry M Karnitz
Journal:  Mol Pharmacol       Date:  2015-10-22       Impact factor: 4.436

10.  Checkpoint signaling, base excision repair, and PARP promote survival of colon cancer cells treated with 5-fluorodeoxyuridine but not 5-fluorouracil.

Authors:  Liyi Geng; Amelia M Huehls; Jill M Wagner; Catherine J Huntoon; Larry M Karnitz
Journal:  PLoS One       Date:  2011-12-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.